BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28517335)

  • 1. SU-E-T-208: The Secondary Malignancy Risk Estimation Due to the Neutron Contamination in 3D-CRT and IMRT Treatment Techniques by Using Bubble Detectors.
    Biltekin F; Özyigit G; Celik D; Yeginer M; Akyol F; Cengiz M; Yildiz F
    Med Phys; 2012 Jun; 39(6Part13):3751. PubMed ID: 28517335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Photoneutron Dose Measured by Bubble Detectors in Conventional Linacs and Cyberknife Unit: Effective Dose and Secondary Malignancy Risk Estimation.
    Biltekin F; Yeginer M; Ozyigit G
    Technol Cancer Res Treat; 2016 Aug; 15(4):560-5. PubMed ID: 26152750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
    Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
    Reft CS; Runkel-Muller R; Myrianthopoulos L
    Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.
    Hälg RA; Besserer J; Boschung M; Mayer S; Lomax AJ; Schneider U
    Phys Med Biol; 2014 May; 59(10):2457-68. PubMed ID: 24778349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating in-field and out-of-field neutron contamination in high-energy medical linear accelerators based on the treatment factors of field size, depth, beam modifiers, and beam type.
    Biltekin F; Yeginer M; Ozyigit G
    Phys Med; 2015 Jul; 31(5):517-23. PubMed ID: 25873196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neutron dose equivalent evaluation and shielding at the maze entrance of a Varian Clinac 23EX treatment room.
    Wang X; Esquivel C; Nes E; Shi C; Papanikolaou N; Charlton M
    Med Phys; 2011 Mar; 38(3):1141-9. PubMed ID: 21520826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.
    Bednarz B; Hancox C; Xu XG
    Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the measurement of photo-neutron for15 MV photon beam from medical linear accelerator under different irradiation geometries using passive detectors.
    Thekkedath SC; Raman RG; Musthafa MM; Bakshi AK; Pal R; Dawn S; Kummali AH; Huilgol NG; Selvam TP; Datta D
    J Cancer Res Ther; 2016; 12(2):1060-4. PubMed ID: 27461699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SU-E-T-587: Whole IMRT, Hybrid IMRT and 3D Conformal Plan a Dosimetric Comparison for Large Target.
    Sharma S; Manigandan D; Gandhi A; Subramani V; Sharma D; Kumar P; Julka P; Rath G
    Med Phys; 2012 Jun; 39(6Part19):3840-3841. PubMed ID: 28517101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
    Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
    Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies.
    Howell RM; Hertel NE; Wang Z; Hutchinson J; Fullerton GD
    Med Phys; 2006 Feb; 33(2):360-8. PubMed ID: 16532941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator.
    Wiezorek T; Voigt A; Metzger N; Georg D; Schwedas M; Salz H; Wendt TG
    Strahlenther Onkol; 2008 Feb; 184(2):73-9. PubMed ID: 18259698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator.
    Vanhavere F; Huyskens D; Struelens L
    Radiat Prot Dosimetry; 2004; 110(1-4):607-12. PubMed ID: 15353716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral photon and neutron doses from prostate cancer external beam irradiation.
    Bezak E; Takam R; Marcu LG
    Radiat Prot Dosimetry; 2015 Dec; 167(4):591-601. PubMed ID: 25564673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
    Chibani O; Ma CM
    Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of non-target organ doses using MOSFET dosemeters for selected IMRT and 3D CRT radiation treatment procedures.
    Wang B; Xu XG
    Radiat Prot Dosimetry; 2008; 128(3):336-42. PubMed ID: 17627959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
    Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.